TenNor Therapeutics Limited a clinicalstage biopharmaceutical company dedicated to research and development of differentiated products for the treatment of diseases associated with bacterial infections and dysbioses
Cure Genetics announced a collaboration with Boehringer Ingelheim to develop novel AdenoAssociated Virus AAV vectorsleveraging Cure Genetics proprietary VELPTM platform to develop nextgeneration gene therapies
RTMS Incand Terix Pharmaceuticals Limited Terixs TLX prostate cancer imaging product using multiple curry units of gallium Ga manufactured on a cyclotron through a proprietary Quantum Irradiation System QIS solidstate targeting system
Jubilant Therapeutics Inc a biopharmaceutical company advancing small molecule modulators to address unmet medical needs in oncology and autoimmune diseases announced a collaboration with The Wistar Institute an international leader in biomedical research
Tessa Therapeutics Tessa a clinicalstage cell therapy company developing nextgeneration cancer treatments for hematological malignancies and solid tumors today announced that the European Medicines Agency EMA has granted PRiority MEdicines PRIME designation
Sirnaomics Inc a biopharmaceutical company engaged in the discovery and development of RNAi therapeutics against cancer and fibrotic diseasesannounced dose administration for the first patient in a Phase a clinical study of the companys lead drug candidate STP for the treatment of cutaneous basal ce...
Sirnaomics Inc a biopharmaceutical company engaged in the discovery and development of RNAi therapeutics against cancer and fibrotic diseases announced dose administration for the first patient in a Phase a clinical study of the companys lead drug candidate STP for the treatment of cutaneous basal c...
Everest Medicines a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients in Greater China and other parts of Asia
Hilton London Kensington
Abstract This study investigates amorphous technologies to improve the dissolution rate and oral bioavailability of flubendazole FLU The selected approaches are a standard spraydried dispersion with hydroxypropylmethylcellulose HPMC E or polyvinylpyrrolidonevinyl acetate both with Vitamin E dtocopheryl polyethylene glycol succinate
Introduction Xceleron is a world leader in the use of Accelerator Mass Spectrometry AMS analytical technology in pharmaceutical food technology crop protection and biobased product applications Our primary business is in pharmaceutical research and development Since we have been helping to design preclinical and clinical investigations around the
Introduction The global CMO market is said to reach USD billion by Patent expiry of drugs stringent price regulations especially in Europe US to purchase drugs from pharma companies Government budget cuts for pharma RD these are the forces which are expected to reshape the future of pharma and the CMO industry At least manufacturing facilities owned by pharma companies were shut dow
The cyberphysical security is no longer an area that should be overlooked Unfortunately cyberphysical attacks of all kinds may cost companies a great...